• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mangalam Drugs and Organics Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20249.0
  • ISIN : INE584F01014
29.18 0 (-0.10%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    29.14

  • Today’s High

    29.62

  • Open

    29.60

  • Perv Close

    29.21

  • 52W Low

    22.80

  • 52W High

    67.19

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    46.19

  • Div & Yield %

    0.00

  • Book Value(₹)

    65.28

  • Debt-Equity Ratio

    -0.10

  • AGM Date

    03-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.79

  • Mar.Cap (₹Cr.)

    46.19

  • RONW (%)

    -6.68

  • ROCE (%)

    1.16

Score Board

  • Equity (₹ in Cr.)

    15.83

  • BV (₹)

    65.30

  • Sales( ₹ in Cr.)

    232.13

  • NP (in Cr.)

    -43.86

  • NP Var(%)

    -741.0

  • Div%

    0.0

  • CPS (₹)

    -16.40

  • EPS (₹)

    -27.70

  • Traded Value (₹ in Lakhs)

    46.17

  • 52 Week High

    67.19

  • 52 Week Low

    22.80

  • Price BSE

    29.0

  • Price NSE

    29.00

  • Market Capital( in Cr.)

    46.17

  • P/C Ratio

    -1.80

  • P/E Ratio

    -1.00

  • Price Vs.BV

    -27.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 232.13 317.58 368.59 372.25 451.07 379.98
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 232.13 317.58 368.59 372.25 451.07 379.98
Other Income 0.76 1.15 0.12 0.44 0.09 4.72
Stock Adjustments -32.08 21.52 -9.10 42.16 33.75 4.23
Total Income 200.81 340.25 359.61 414.85 484.91 388.93
EXPENDITURE :            
Raw Materials 124.79 188.89 235.41 292.60 340.39 256.19
Power and Fuel Cost 18.29 27.88 28.50 25.59 22.90 16.12
Employee Cost 33.46 40.59 39.07 34.61 37.25 29.88
Other Manufacturing Expenses 7.49 15.24 13.26 11.58 11.92 8.11
Selling and Administration Expenses 17.96 17.78 13.10 11.60 13.64 16.19
Miscellaneous Expenses 12.76 13.57 12.78 12.71 9.67 4.42
Employee Benefit Expenses 33.46 40.59 39.07 34.61 37.25 29.88
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 214.75 303.95 342.12 388.69 435.77 330.91
Operating Profit -13.93 36.30 17.49 26.16 49.14 58.02
Interest 16.21 14.93 13.92 12.96 11.16 9.33
Gross Profit -30.14 21.37 3.57 13.20 37.98 48.69
Depreciation 17.84 16.38 14.63 10.99 10.25 9.18
Profit Before Tax -47.98 4.99 -11.06 2.21 27.73 39.51
Current Tax 0.29 0.08 0.19 -0.03 8.81 9.27
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.46 -2.02 -2.20 0.97 -0.73 2.28
Reported Net Profit -43.81 6.92 -9.05 1.27 19.66 27.97
Extraordinary Items 0.04 0.09 -0.05 0.00 0.06 0.00
Adjusted Net Profit -43.85 6.83 -9.00 1.27 19.60 27.97
Adjustment below Net Profit -1.52 -0.62 -0.56 0.12 0.12 -1.12
P & L Balance brought forward 99.66 93.35 102.96 101.57 81.79 54.94
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 54.33 99.66 93.35 102.96 101.57 81.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -27.68 4.37 -5.72 0.80 12.42 17.67
Earnings Per Share(Adj)-Unit Curr -27.68 4.37 -5.72 0.80 12.42 17.67
Book Value 65.28 93.92 89.93 96.00 95.12 82.63
Book Value(Adj)-Unit Curr 65.28 93.92 89.93 96.00 95.12 82.63

Shareholding Pattern

  • Promoter Group

    35.65%

  • Public Share Holding

    64.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,632,682 16.63 2,632,682 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,010,348 19.02 3,010,348 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,643,030 35.65 5,643,030 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 306 0.00 306 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 17,505 0.11 17,505 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,811 0.11 17,811 3
2] Non Institution
Bodies Corporate 122,957 0.78 122,957 67
Clearing Members 8,659 0.05 8,659 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 206,926 1.31 206,926 341
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 248,927 1.57 248,927 331
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,659,375 10.48 1,659,375 38
Individuals holding nominal share capital up to Rs. 1 lakh 7,917,337 50.02 7,917,337 23,183
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,167,407 64.24 10,167,407 23,971
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,828,248 100.00 15,828,248 23,991

Company Background

Mangalam Drugs and Organics LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mangalam Drugs and Organics Ltd
  • BSE Code : 20249.0
  • ISIN : INE584F01014

  • Incorporation Year

    1972

  • Registered Office

    3rd Floor Rupam Building
    239 P D Mello Road, Mumbai,
    Maharashtra-400001

  • Telephone

    91-22-22616200/6300/8787

  • FAX

    91-22-26190900

  • Chairman

    Govardhan M Dhoot

  • Managing Director

    Govardhan M Dhoot

  • Company Secretary

  • Auditor

    V S Somani & Co/S N Nanda & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Mangalam Drugs and Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mangalam Drugs 29.34 232.90 232.13 -1.23 -13.61
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77